Oil Is the New Gold
Health Care: Drugs
Regulus Therapeutics Inc (RGLS: NASDAQ)
$9.94 0.04 | 0.40%
06/19/13 - 01:30 PM ET
126.47K / 78.60K
Vol / Avg. Vol:9.93 / 9.90
Open / Prev. Close:9.90 - 10.05
Today's Range:4.02 - 10.40
52 Wk Range:56.67%
Performance YTD:TheStreet Rating:
Portfolios with RGLS
- Portfolio NameUser Type
Latest RGLS Headlines from TheStreet
- 8 Stocks Roaring Higher on Unusual Volume 12.27.12 | 03:12 pm
- Cramer's 'Mad Money' Recap: Focus on What Matters 10.15.12 | 07:10 pm
- IPOs: LifeLock, Luxfer, Regulus
10.02.12 | 06:10 am
Press Releases for RGLS
- Regulus Names Stelios Papadopoulos, Ph.D. As Chairman Of Its Board Of Directors - PR Newswire 06.11.13 | 08:06 am
- Regulus To Present At Deutsche Bank 38th Annual Healthcare Conference - PR Newswire 05.21.13 | 04:05 pm
- Regulus Announces Timing For First Quarter 2013 Financial Results Webcast And Conference Call - PR Newswire 05.07.13 | 04:05 pm
- Regulus To Present At 12th Annual Needham Healthcare Conference - PR Newswire 04.24.13 | 04:04 pm
- Zosano Pharma, Inc. Expands Board Of Directors With Addition Of Kleanthis G. Xanthopoulos, Ph.D. - PR Newswire 04.15.13 | 11:04 am
- Regulus Appoints William H. Rastetter, Ph.D. To Its Board Of Directors - PR Newswire 04.01.13 | 08:04 am
- Regulus To Present At Future Leaders In The Biotech Industry Conference - PR Newswire 03.28.13 | 04:03 pm
- Regulus To Present At Cowen And Company 33rd Annual Healthcare Conference - PR Newswire 02.26.13 | 04:02 pm
- Regulus Announces Timing For Fourth Quarter And Year-End 2012 Financial Results Webcast And Conference Call - PR Newswire 02.13.13 | 04:02 pm
- Regulus To Present At Two Upcoming Investor Conferences - PR Newswire 02.04.13 | 04:02 pm
Partner Headlines for RGLS
- UPDATE: Wedbush Securities Initiates Regulus Therapeutics at Outperform on Pipeline Progress - Benzinga 11.29.12 | 01:11 pm
- Regulus Therapeutics: Serious Red Flags At This Public Offering - Seeking Alpha 10.08.12 | 09:10 am
- Six More IPOs this Week - NASDAQ 10.05.12 | 09:10 pm
